AVITA Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10.24	14.05	22.12	18.16	55.51
Short-Term Investments	7.94	21.84	66.94	61.18	29.65
Cash & Short-Term Investments	18.19	35.89	89.06	79.34	85.16
Cash Growth	-49.32%	-59.71%	12.24%	-6.83%	-23.10%
Accounts Receivable	9.09	11.79	7.69	3.53	3.43
Other Receivables	0.02	0.12	0.23	1.18	0.09
Receivables	9.11	11.91	7.92	4.71	3.51
Inventory	6.93	7.27	5.6	2.13	2.13
Prepaid Expenses	1.27	1.94	1.43	0.92	1.12
Restricted Cash	-	-	-	-	0.2
Other Current Assets	-	-	-	0.36	0
Total Current Assets	35.49	57	104.01	87.46	92.13
Property, Plant & Equipment	11.53	13.59	4.32	2.05	2.81
Long-Term Investments	-	-	-	6.93	19.69
Other Intangible Assets	5.65	5.57	0.49	0.47	0.44
Long-Term Deferred Charges	-	-	-	-	0.5
Other Long-Term Assets	3.73	3.55	2.83	1.36	0.44
Total Assets	56.39	79.71	111.64	98.26	116.02
Accounts Payable	8.96	6.29	3.79	3	2.71
Accrued Expenses	8.09	12.55	8.14	6.7	5.36
Current Portion of Long-Term Debt	42.98	-	-	-	-
Current Portion of Leases	0.93	0.9	0.9	0.61	0.72
Current Unearned Revenue	0.03	0.03	0.03	-	-
Other Current Liabilities	1.68	0.39	0.34	0.38	0.36
Total Current Liabilities	62.68	20.16	13.2	10.69	9.15
Long-Term Debt	-	42.25	39.81	-	-
Long-Term Leases	2.14	2.84	1.7	0.31	0.92
Long-Term Unearned Revenue	0.29	0.32	0.36	0.7	0.95
Other Long-Term Liabilities	7.94	9.65	7.51	1.83	0.38
Total Liabilities	73.04	75.21	62.58	13.52	11.39
Common Stock	0	0	0	0	0
Additional Paid-In Capital	394.41	367.57	350.04	339.83	332.48
Retained Earnings	-408.4	-359.81	-297.97	-262.59	-235.92
Comprehensive Income & Other	-2.66	-3.26	-3.02	7.5	8.06
Shareholders' Equity	-16.65	4.5	49.06	84.74	104.62
Total Liabilities & Equity	56.39	79.71	111.64	98.26	116.02
Total Debt	46.05	45.99	42.41	0.92	1.64
Net Cash (Debt)	-27.86	-10.1	46.65	85.35	103.21
Net Cash Growth	-	-	-45.35%	-17.30%	-5.45%
Net Cash Per Share	-1.00	-0.39	1.84	3.41	4.24
Filing Date Shares Outstanding	30.63	26.36	25.71	25.3	24.93
Total Common Shares Outstanding	30.57	26.35	25.68	25.21	24.93
Working Capital	-27.19	36.84	90.81	76.77	82.99
Book Value Per Share	-0.54	0.17	1.91	3.36	4.20
Tangible Book Value	-22.3	-1.07	48.57	84.28	104.18
Tangible Book Value Per Share	-0.73	-0.04	1.89	3.34	4.18
Machinery	6.28	6.2	3.02	1.97	1.88
Construction In Progress	0.02	0.44	0.09	0.26	0.03
Leasehold Improvements	4.88	4.61	0.37	0.26	0.24

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q